Antibiotics and antivirals for dementia and mild cognitive impairment
References
Additional references
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994.
Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Medical Microbiology and Immunology (Berlin) 1998;187(1):23‐42.
Cacabelos R. Pharmacogenomics and therapeutic prospects in dementia. European Archives of Psychiatry and Clinical Neuroscience 2008;258(Suppl 1):28‐47.
Chessell IP, Procter AW, Francis PT, Bowen DM. D‐cycloserine, a putative cognitive enhancer, facilitates activation of the N‐methyl‐D‐aspartate receptor‐ionophore complex in Alzheimer brain. Brain Research 1991;565(2):345‐348.
Dubois D, Feldman H, Jacova C, DeKosky ST, Barberger‐Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer’s disease:revising the NINCDS–ADRDA criteria. Lancet Neurologu 2007;6:734‐46.
US Food and Drug Administration. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/default.htm.
Ferri C, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366(9503):2112‐17.
Forloni G, Colombo L, Girola L, Tagliavini F, Salmona M. Anti‐amyloidogenic activity of tetracyclines: studies in vitro. FEBS Letters 2001;487(3):404‐7.
Alessio Galbussera, Lucio Tremolizzo, Valeria Isella, Giorgio Gelosa, Roberto Vezzo, Luigi Vigore`, Marzia Brenna, Carlo Ferrarese, Ildebrando Appollonio. Lack of Evidence for Borrelia burgdorferi Seropositivity in Alzheimer Disease. Alzheimer Dis Assoc Disord July–September, 2008;22(3):308.
Ezio Giacobinia, Robert E. Becker. One Hundred Years after the Discovery of Alzheimer??s Disease. A Turning Point for Therapy?. Journal of Alzheimer’s Disease 2007;12:37–52.
Giamarellos‐Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators. International Journal of Antimicrobial Agents 2008;31:12‐20.
Gieffers J, Reusche E, Solbach W, Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. Journal of Clinical Microbiology 2000;38(2):881‐2.
Giovanni Ravaglia, MD, Paola Forti, MD, Fausta Montesi, MD, Anna Lucicesare, MD, Nicoletta Pisacane, MD, Elisa Rietti, MD, Edoardo Dalmonte, MD, Marisa Bianchin, MD, Patrizia Mecocci, MD. Mild Cognitive Impairment: Epidemiology and Dementia Risk in an Elderly Italian Population. J Am Geriatr Soc 2008;56:51–58.
Gutacker M, Valsangiacomo C, Balmelli T, Bernasconi M.V, Bouras C, Piffaretti J. Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer's disease. Research in Microbiology 1998;149:31‐7.
Hideki Yamamoto, Takuya Watanabe, Akira Miyazaki, Takashi Katagiri, Tsunenori Idei, Takashi Iguchi, Masaru Mimura, Kunitoshi Kamijima. High Prevalence of Chlamydia Pneumoniae Antibodies and Increased High‐Sensitive C‐Reactive Protein in Patients with Vascular Dementia. J Am Geriatr Soc 2005;53(4):583‐589.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain andrisk of Alzheimer’s disease.. Lancet 1997;349:241–244.
Itzhaki, R. F, Wozniak, M. A, Appelt, D. M, Balin, B. J. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiology of Aging 2004;25:619‐627.
Itzhaki RF, Wozniak MA. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. Prog Lipid Res 2006;45:73‐90.
Jones R, Laake K, Oeksengaard AR. D‐cycloserine for Alzheimer's disease. The Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD003153]
Kern JM, Maass V, Maass M. Chlamydia pneumoniae‐induced pathological signaling in the vasculature. FEMS Immunol Med Microbiol 2009;55(2):131‐139.
Leissring M.A, Sugarman M.C, LaFerla F.M. Herpes Simplex Virus Infections and Alzheimer's Disease: Implications for Drug Treatment and Immunotherapy. Drugs & Aging 1 September 1998;13(3):193‐198.
Lellouch‐Tubiana A, Fohlen M, Robain O, Rozenberg F. Immunocytochemical characterization of long‐term persistentimmune activation in human brain after Herpes simplex encephalitis. Neuropathol Appl Neurobiol 2000;26(3):285–294.
W R Lin, I Casas, G K Wilcock, R F Itzhaki. Neurotropic viruses and Alzheimer's disease: a search for varicella zoster virus DNA by the polymerase chain reaction. J Neurol Neurosurg Psychiatry 1997 June;62(6):586‐589.
Lin WR, Jennings R, Smith TL, Wozniak MA, Itzhaki RF. Vaccination prevents latent HSV1 infection of mouse brain.. Neurobiol Aging 2001;22(5):699‐703.
Little, C. S, Hammond, C. J, MacIntyre, A, Balin, B. J, Appelt, D. M. Chlamydia pneumoniae induces Alzheimer‐like amyloid plaques in brains of BALB/c mice. Neurobiology of Aging 2004;25:419‐429.
Mark B. Loeb, D. William Molloy, Marek Smieja, Tim Standish, Charles H. Goldsmith, Jim Mahony, Stephanie Smith, Michael Borrie, Earl Decoteau, Warren Davidson, Allan McDougall, Judy Gnarpe, Martin O’Donnell, Max Chernesky. A Randomized, Controlled Trial of Doxycycline and Rifampinfor Patients with Alzheimer’s Disease. J AmGeriatr Soc 2004;52:381–387.
Mahony, J, Woulfel, J, Munoz, D, Chong, S, Smieja, M. Chlamydia pneumoniae in the Alzheimer's brain ‐ is detection hampered by low copy number?. Proceedings of 4th Meeting of the European Society for Chlamydia Research, Helsinki, Finland. 2000:299‐300.
Marques AR, Weir SC, Fahle GA, Fischer SH. Lack of evidence of Borrelia involvement in Alzheimer's disease. J Infect Dis 2000;182:1006‐7.
MacIntyre, A, Hammond, C. J, Little, C. S, Appelt, D. M, Balin, B. J. Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. FEMS Microbiology Letters 2002;217:167‐172.
MacIntyre, A, Abramov, R, Hammond, C. J, Hudson, A. P, Arking, E. J, Little, C. S, Appelt, D. M, Balin, B. J. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. Journal of Neuroscience Research 2003;71:740‐750.
Middleton PJ, Peteric M, Kozak M, Rewcastle NB, McLachlan DR. Herpes simplex viral genome and senile and presenile dementias of Alzheimer and Pick. Lancet 1980;315:1038.
Miklossy J. Alzheimer’s disease—a spirochetosis?. Neuroreport 1993;4:841‐8.
Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ. Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis. 2004;6(6):639‐649.
Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K. Beta‐amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging 2006;27:228‐36.
Judith Miklossy. Chronic Inflammation and Amyloidogenesis in Alzheimer's Disease ‐‐ Role of Spirochetes. Journal of Alzheimer's Disease 2008;13(4):381‐391.
Judith Miklossy. Chronic Inflammation and Amyloidogenesis in Alzheimer’s Disease – Role of Spirochetes. Journal of Alzheimer’s Disease 2008;13:381–391.
Nochlin D, Shaw CM, Campbell LA, Kuo CC. Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease. Neurology 1999;53(8):1888.
H. Noguchi, J.W. Moore. A demonstration of Treponema pallidum in the brain of general paralysis cases. J Exp Med 1913;17:232–238.
Ossewaarde, J. M, Gielis‐Proper, S. K, Meijer, A, Roholl, P. J. M. Chlamydia pneumoniae antigens are present in the brains of Alzheimer patients, but not the brains of patients with other dementias. Saikku P, (ed.) Proceedings of the fourth meeting of the European Society for Chlamydia Research, Helsinki, Finland. 2000:284.
Bogusław Paradowski, Malgorzata Jaremko, Tadeusz Dobosz, Jerzy Leszek, Leszek Noga. Evaluation of CSF‐Chlamydia pneumoniae, CSF‐tau, and CSF‐Abeta42 in Alzheimer’sdisease and vascular dementia. J Neurol 2007;254:154–159.
Brenda L. Plassman, PhD, Kenneth M. Langa, MD, PhD, Gwenith G. Fisher, PhD, Steven G. Heeringa, PhD, David R. Weir, PhD, Mary Beth Ofstedal, PhD, James R. Burke, MD, PhD, Michael D. Hurd, PhD, Guy G. Potter, PhD, Willard L. Rodgers, PhD, David C. Steffens, MD, MHS, John J. McArdle, PhD, Robert J. Willis, PhD, Robert B. Wallace. MD. Prevalence of Cognitive Impairment without Dementia in the United State. Ann Intern Med 2008;148:427‐434.
Richard B Pyles. The Association of Herpes SimplexVirus and Alzheimer’s Disease: aPotential Synthesis of Genetic andEnvironmental Factors. Association of HSV and AD • HERPES 2001;8(3):64‐68.
Stephen R. Robinson, Curtis Dobson, Joseph Lyons. Challenges and directions for the pathogen hypothesis ofAlzheimer’s disease. Neurobiology of Aging 2004;25:629–637.
Tabert MH, Albert SM, Borukhova‐Milov L, Camacho Y, Pelton G, Liu X, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002;58:758‐764.
Tomiyama T, Shoji A, Kataoka K, Suwa Y, Asano S, Kaneko H. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. Journal of Biological Chemistry 1996;271(12):6839‐44.
World Health Organisation. The ICD‐10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO, 1993.
| Search strategy |
| 1. dementia.ab,kw,sh,ec,ti. |
| 2. Alzheimer.ab,kw,sh,ec,ti. |
| 3. lewy body.ab,kw,sh,ec,ti. |
| 4. (cognit$ or memory$ or mental$).mp. and (declin$ or impair$ or los$ or deteriorat$).ab,ti. |
| 5. 1 or 2 or 3 or 4 |
| 6. Antibiotic$ ti,ab |
| 7. Anti‐bacterial agents .mh |
| 8. Doxycycl$ ti,ab, kw |
| 9. Vibramycin ti, ab, kw |
| 10. Monodoxin ti, ab, kw |
| 11. Liviatin ti, ab,kw |
| 12. Hydramycin ti, ab,kw |
| 13. Rifampin ti, ab,kw |
| 14. Rifampicin ti, ab, kw |
| 15. Fluoroquinolone$ ti, ab,kw |
| 16. Minocycl$ ti, ab, kw |
| 17. Antivir$ ti, ab |
| 18. Anti‐vir$ ti, ab |
| 19. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 |
| 20. randomized controlled trial$.ab,kw,sh,pt,ec,ti. |
| 21. randomised controlled trial$.ab,kw,sh,pt,ec,ti. |
| 22. controlled clinical trial$.ab,kw,sh,pt,ec,ti. |
| 23. randomi$.ab,ti. |
| 24. (double blind$ or single blind$ or triple blind$).ab,sh,ti. |
| 25. (crossover or cross‐over).ab,ti. |
| 26. 20 or 21 or 22 or 23 or 24 or 25 |
| 27. 19 and 26 |
| 28. Limit 27 to Human |
Figures and Tables -
Table 1. MEDLINE search strategy
